✦ LIBER ✦

SGLT2 versus DPP4 inhibitors for type 2 diabetes

✍ Scribed by Scheen, André J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canagliflozin: SGLT2 inhibitor for treat

✍ Donnelly, Richard 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) ⚖ 229 KB

New treatments for type 2 diabetes—The D

✍ Roger Gadsby 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 113 KB

Saxagliptin (Onglyza): new DPP-4 inhibit

✍ Steve Chaplin; Jiten Vora 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 85 KB

Linagliptin: new DPP-4 inhibitor for typ

✍ Zin Htike; Ian Lawrence 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 875 KB

Gliptins: DPP-4 inhibitors to treat type

✍ Brian Green; Peter Flatt; Clifford Bailey 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) ⚖ 141 KB

DPP-4 inhibitors in the treatment of typ

✍ Hélène Duez; Bertrand Cariou; Bart Staels 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 495 KB